Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers
Reem Ali(Hamad bin Khalifa University), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Islam M. Miligy(University of Nottingham), Adel Alblihy(University of Nottingham), Mashael Algethami(University of Nottingham), Alan E. Tomkinson(University of New Mexico), Katia A. Mesquita(University of Nottingham), Stephen Chan(Heidelberg University), Ahmed Shoqafi(University of Nottingham), Tarek M.A. Abdel-Fatah(University of Nottingham), Nigel P. Mongan(University of Nottingham), Pei Wen Chiang(Nottingham University Hospitals NHS Trust), Muslim Alabdullah(Islamic Azad University, Science and Research Branch), Emad A. Rakha(Nottingham University Hospitals NHS Trust)
Cited by 34
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
|Journal of Clinical Oncology|1999|639